Deferred Tax Assets, Valuation Allowance of Arcadia Biosciences, Inc. from 31 Dec 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Arcadia Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2024.
  • Arcadia Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $28,370,000, a 7% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Arcadia Biosciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $28,370,000 -$2,124,000 -7% 31 Dec 2024 10-K 25 Mar 2025 2024 FY
Q4 2023 $30,494,000 +$3,727,000 +14% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q4 2022 $26,767,000 +$6,262,000 +31% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $20,505,000 -$6,000 -0.03% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $20,511,000 +$1,938,000 +10% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $18,573,000 -$25,927,000 -58% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $44,500,000 +$3,197,000 +7.7% 31 Dec 2018 10-K 25 Mar 2020 2019 FY
Q4 2017 $41,303,000 -$14,329,000 -26% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q4 2016 $55,632,000 +$8,460,000 +18% 31 Dec 2016 10-K 20 Mar 2018 2017 FY
Q4 2015 $47,172,000 +$6,607,000 +16% 31 Dec 2015 10-K 08 Mar 2017 2016 FY
Q4 2014 $40,565,000 31 Dec 2014 10-K 08 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.